George Mcbride, PMHNP-BC

NPI: 1962061473
Total Payments
$3,722
2024 Payments
$331.31
Companies
18
Transactions
189
Medicare Patients
398
Medicare Billing
$64,539

Payment Breakdown by Category

Food & Beverage$3,722 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,722 189 100.0%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $569.77 34 $0 (2024)
Otsuka America Pharmaceutical, Inc. $477.10 23 $0 (2024)
ABBVIE INC. $393.68 17 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $362.27 17 $0 (2023)
Alkermes, Inc. $320.65 17 $0 (2023)
Neurocrine Biosciences, Inc. $288.61 13 $0 (2024)
ITI, Inc. $277.36 15 $0 (2022)
Sunovion Pharmaceuticals Inc. $262.83 12 $0 (2022)
Lundbeck LLC $165.50 9 $0 (2023)
Supernus Pharmaceuticals, Inc. $132.17 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $331.31 17 Neurocrine Biosciences, Inc. ($87.29)
2023 $776.63 42 Teva Pharmaceuticals USA, Inc. ($177.75)
2022 $1,649 78 ABBVIE INC. ($353.82)
2021 $965.86 52 Takeda Pharmaceuticals U.S.A., Inc. ($151.13)

All Payment Transactions

189 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/23/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $30.74 General
Category: VILOXAZINE HYDROCHLORIDE
12/05/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.52 General
Category: Central Nervous System
11/19/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $22.08 General
Category: Neuropsychiatry
11/07/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $6.65 General
Category: CNS Stimulant for ADHD
11/04/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $27.48 General
Category: VILOXAZINE HYDROCHLORIDE
10/15/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $22.82 General
Category: Neuropsychiatry
10/08/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $24.25 General
Category: Central Nervous System
09/30/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $8.37 General
Category: CNS Stimulant for ADHD
09/11/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $22.16 General
Category: Central Nervous System
08/13/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $27.87 General
Category: Neuropsychiatry
05/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.52 General
Category: Neuropsychiatry
05/07/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $16.59 General
Category: PSYCHIATRY
05/01/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $20.79 General
Category: Central Nervous System
04/09/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $7.17 General
Category: CNS Stimulant for ADHD
04/03/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $26.12 General
Category: PSYCHIATRY
02/07/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $6.80 General
Category: CNS Stimulant for ADHD
02/06/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $29.38 General
Category: PSYCHIATRY
11/14/2023 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $6.40 General
Category: Central Nervous System
11/07/2023 Supernus Pharmaceuticals, Inc. QELBREE (Drug) Food and Beverage Cash or cash equivalent $14.98 General
Category: PSYCHOLOGY
10/24/2023 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $30.23 General
Category: NEUROSCIENCE
10/17/2023 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $24.66 General
Category: PSYCHIATRY
10/11/2023 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $4.67 General
Category: Central Nervous System
10/03/2023 IDORSIA PHARMACEUTICALS US INC QUVIVIQ (Drug) Food and Beverage In-kind items and services $22.52 General
Category: INSOMNIA
09/26/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $29.04 General
Category: PSYCHIATRY
09/19/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $20.70 General
Category: CNS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 149 393 $53,395 $23,774
2022 2 87 267 $31,350 $14,901
2021 3 88 272 $32,950 $15,710
2020 3 74 215 $26,700 $10,153
Total Patients
398
Total Services
1,147
Medicare Billing
$64,539
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 59 223 $31,220 $15,381 49.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 48 98 $9,800 $3,873 39.5%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 27 27 $6,750 $2,780 41.2%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 15 45 $5,625 $1,740 30.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 57 236 $23,600 $11,727 49.7%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 30 31 $7,750 $3,174 41.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 42 217 $21,700 $11,013 50.8%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 30 30 $7,500 $3,553 47.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 16 25 $3,750 $1,145 30.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 32 149 $14,900 $6,307 42.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 23 47 $7,050 $2,228 31.6%
90792 Psychiatric diagnostic evaluation with medical services Office 2020 19 19 $4,750 $1,618 34.1%

About George Mcbride, PMHNP-BC

George Mcbride, PMHNP-BC is a Psychiatric/Mental Health healthcare provider based in Cleveland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2019. The National Provider Identifier (NPI) number assigned to this provider is 1962061473.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, George Mcbride, PMHNP-BC has received a total of $3,722 in payments from pharmaceutical and medical device companies, with $331.31 received in 2024. These payments were reported across 189 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,722).

As a Medicare-enrolled provider, Mcbride has provided services to 398 Medicare beneficiaries, totaling 1,147 services with total Medicare billing of $64,539. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Cleveland, TN
  • Active Since 06/08/2019
  • Last Updated 06/08/2019
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • NPI Number 1962061473

Products in Payments

  • VRAYLAR (Drug) $393.68
  • AUSTEDO (Drug) $379.77
  • TRINTELLIX (Drug) $362.27
  • REXULTI (Drug) $352.99
  • INGREZZA (Drug) $288.61
  • CAPLYTA (Drug) $277.36
  • ABILIFY MAINTENA (Drug) $270.93
  • LATUDA (Drug) $262.83
  • LYBALVI (Drug) $215.52
  • Austedo XR (Drug) $161.48
  • SPRAVATO (Drug) $112.57
  • ARISTADA (Drug) $84.19
  • NEUROSTAR TMS THERAPY SYSTEM (Device) $79.93
  • QELBREE (Drug) $73.95
  • QUVIVIQ (Drug) $67.95
  • Qelbree (Drug) $58.22
  • FANAPT (Drug) $36.37
  • APLENZIN (Drug) $33.81
  • HETLIOZ (Drug) $33.81
  • Azstarys (Drug) $28.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Cleveland